Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.5K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.5K
Experimental RNAi02:15

Experimental RNAi

8.0K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.0K
Leaky Scanning02:28

Leaky Scanning

5.8K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.8K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

7.0K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
7.0K
Abnormal Proliferation02:23

Abnormal Proliferation

5.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

10.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SARS-CoV-2 enhances lysosomal exocytosis and deacidifies lysosomes to facilitate viral release.

mLife·2026
Same author

<i>UBA1-CDK16</i>: A female-specific chimeric RNA emerging through evolution and involved in immune regulation.

Science advances·2026
Same author

Programmable, target-induced fluorogenic CRISPR-tDeg platform for live-cell RNA visualization.

Nucleic acids research·2026
Same author

Revealing the role of U2AF1 in splicing regulation and chimeric RNA dynamics.

Scientific reports·2025
Same author

Landscape of chimeric RNAs in COVID-19 patient blood.

Genes & diseases·2025
Same author

<i>UBA1-CDK16</i> : A Sex-Specific Chimeric RNA and Its Role in Immune Sexual Dimorphism.

bioRxiv : the preprint server for biology·2024

Related Experiment Video

Updated: Feb 19, 2026

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

1.4K

Chimeric RNAs and their implications in cancer.

Zi Li1, Fujun Qin2, Hui Li2

  • 1Department of Pathology, University of Virginia, Charlottesville, VA 22908, USA; Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha 410011, China.

Current Opinion in Genetics & Development
|November 4, 2017
PubMed
Summary

Chimeric RNAs are not exclusive to cancer and can arise from various mechanisms beyond gene fusions. Understanding these non-canonical chimeric RNAs is crucial for advancing cancer detection and treatment strategies.

More Related Videos

Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients
08:25

Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients

Published on: September 9, 2020

11.9K
Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

1.2K

Related Experiment Videos

Last Updated: Feb 19, 2026

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

1.4K
Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients
08:25

Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients

Published on: September 9, 2020

11.9K
Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

1.2K

Area of Science:

  • Molecular Biology
  • Genomics
  • Cancer Research

Background:

  • Chimeric RNAs were historically considered unique to cancer, arising from chromosomal rearrangements and gene fusions.
  • Detected chimeric RNAs were often used as indicators for the presence of gene fusions in cancer.

Purpose of the Study:

  • To challenge the notion that chimeric RNAs are exclusively cancer-specific.
  • To highlight the prevalence and diverse origins of chimeric RNAs in non-cancerous cells.
  • To emphasize the potential of non-canonical chimeric RNAs in cancer diagnostics and therapeutics.

Main Methods:

  • Review of recent scientific literature on chimeric RNA detection and characterization.
  • Analysis of studies investigating chimeric RNA biogenesis in both cancerous and non-cancerous contexts.
  • Exploration of emerging research on non-canonical chimeric RNA mechanisms.

Main Results:

  • Chimeric RNAs are widely detected in non-cancerous cells and tissues, not solely in cancer.
  • Mechanisms beyond chromosomal rearrangement contribute to chimeric RNA formation.
  • The field of non-canonical chimeric RNAs is nascent, facing challenges in terminology and standardization.

Conclusions:

  • Chimeric RNAs are not exclusive hallmarks of cancer.
  • Non-canonical chimeric RNAs represent a significant area for future research.
  • Understanding diverse chimeric RNA origins may revolutionize cancer detection and treatment.